Two scientists combine complementary strengths in RNA biology and aging neuron research to advance new approaches in studying ALS: Ross Buchan and Kevin Rhine are using a new effort at the University of Arizona BIO5 Institute to bring faculty and clinicians together across disciplines to better understand, and ultimately treat, ALS.